drugset / Trial / NCT00027664
Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
RandomizedTreatment
Summary
RATIONALE: Interferon alfa may interfere with the growth of cancer cells. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. It is not yet known if interferon alfa is more effective with or without thalidomide in treating metastatic kidney cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of interferon alfa with or without thalidomide in treating patients who have metastatic kidney cancer.
Timeline
- Start
- 2001-02
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | — | Oral |
| Subject | interferon alfa-2b | Protein / enzyme biologic | — | Subcutaneous |